Skip to main content
NIHPA Author Manuscripts logoLink to NIHPA Author Manuscripts
. Author manuscript; available in PMC: 2016 May 9.
Published in final edited form as: J Allergy Clin Immunol. 2014 Sep 22;134(6):1453–1456. doi: 10.1016/j.jaci.2014.07.032

Dry roasting enhances peanut allergic sensitization across mucosal and cutaneous routes in mice

Amin E Moghaddam a,*, William R Hillson a,*, Mario Noti b, Kate H Gartlan a, Steven Johnson a, Benjamin Thomas a, David Artis b, Quentin J Sattentau a
PMCID: PMC4861634  NIHMSID: NIHMS776126  PMID: 25253515

To the Editior

The reasons for the disproportionate contribution of peanuts to prevalent and severe cases of food allergy in the Western world are unclear. Emerging statistics from East Asia generally match the overall common food allergies in the West, with the striking exception of peanuts, which are consumed equivalently in both regions.1, 2 Differences in peanut preparation, roasted and dry-roasted (DR) in the West versus raw, boiled, or fried in the East, have been proposed to contribute to this trend,13 and are supported by serological studies.1, 4 Results obtained with other proteins have highlighted the potential immunomodulatory properties of advanced glycation end products (AGE),5 which are extensively formed during the high temperature dry roasting of peanuts.6 However, despite this information, the immunogenicity and allergenicity of raw compared to DR peanuts has not been characterized in vivo.

To address this, we first primed BALB/c mice subcutaneously (SC) with endotoxin-depleted soluble fractions of peanut protein extract (PPE) from raw or DR peanuts in PBS without adjuvant (see Fig E1, A, E2, and E3, A, and Methods in this article’s Online Repository at www.jacionline.org). This resulted in enhanced peanut-specific IgG titers in DR-primed groups across a range of doses, reactive against both raw and DR peanut extracts, and with a dominant IgG1:IgG2a bias (see Fig E4, AC, in this article’s Online Repository at www.jacionline.org). After three subsequent intra-gastric (IG) gavages of endotoxin-undetectable DR crude peanut homogenate (CPH; see Fig E2, and E3, A), anti-raw peanut IgG titres rose by an average of 100-fold more in the DR compared to the raw PPE group, and was associated with significant titers of anti-raw IgE, functional in basophil degranulation (Fig 1, A and B). Mesenteric lymph node (MLN) cells from DR but not raw PPE-primed mice proliferated robustly in response to raw and DR PPE, and cytokines produced were dominated by IL-4 and IL-5 but not IFN-γ and TNF-α (Fig 1, C and D, and see Fig E4, D and E). This pattern of enhanced DR PPE immunogenicity was maintained in a similar experiment, where PPE and CPH were kept homologous (raw/raw or DR/DR) during the SC prime and IG exposures (see Fig E4, F). In a further experiment we fed mice previously primed with DR or raw PPE with raw peanut kernels (see Fig E3, B) and observed significantly increased anti-raw and anti-DR PPE IgE only in DR-primed mice (Fig 1, E, and see E4, G). Finally, we excluded SC priming and directly administered multiple adjuvant-free IG CPH gavages (see Fig E3, C, and Repository Methods). DR but not raw CPH elicited anti-peanut IgG1 and functional IgE responses (Fig 1, FH, and see Fig E5 in this article’s Online Repository at www.jacionline.org).

FIG 1. Immunogenicity of raw and dry-roasted (DR) peanut extracts in BALB/c mice.

FIG 1

A, SC-primed, post-IG gavage anti-raw PPE IgG and IgE, and B, IgE RBL degranulation. C–D, 3[H]thymidine incorporation and cytokines in raw PPE-pulsed MLN cell cultures from experiment in (A). E, Anti-raw PPE IgE responses to SC sensitization and raw peanut feeding. F–H, Anti-raw PPE antibody and RBL degranulation to direct GI sensitization. I and J, Anti-raw PPE antibody responses to EC sensitization. K, Eosinophils (arrow heads) in H&E staining of jejunum lamina propria. L, Flow cytometric analysis of disaggregated lamina propria (LP) and M, PPE-pulsed MLN cell cytokines.

Atopic dermal sensitization could be highly relevant to peanut allergy.7 We therefore adopted an epicutaneous (EC) sensitizing strategy described previously (see Fig E3, D, and Repository Methods), with raw or DR PPE applied daily to a developing atopic dermatitis-like skin lesion induced by topical administration of the exfoliating vitamin D analogue calcipotriol (MC903). Subsequent IG gavage and whole peanut feeding elicited higher peanut-specific IgG and IgE titers in the DR compared to raw PPE-sensitized mice (Fig 1, I and J, and see Fig E6 in this article’s Online Repository at www.jacionline.org). Moreover, DR PPE-sensitized mice showed higher eosinophilic infiltration of lamina propria (LP) and increased IL-4, IL-5 and IL-13 secretion by MLN cells (Fig 1, KM). Taken together, these data consolidate an enhanced Th2/allergenic profile of DR compared to raw peanuts, maintained across SC, EC and GI routes of sensitization.

Dry roasting modifies the physicochemical properties of peanut proteins via the Maillard reaction, in a manner that may influence protein immunogenicity via cross-linking and/or AGE adduction.46 We excluded cross-linking as a major contributor to immunogenicity since our DR PPE samples underwent multiple rounds of filtration and centrifugation that depleted cross-linked species (see Fig E1). Furthermore, we purified major peanut allergen Ara h1 from PPE and observed by native gel electrophoresis and multi-angle light scattering that compared to raw, DR peanut-derived Ara h1 retained fewer multimers (see Fig E1, C and D), yet was more immunogenic in a SC immunization of BALB/c mice (see Fig E3, E and E4, H). However, consistent with the presence of AGE-related adducts,6 DR but not raw Ara h1 bound to two well-characterized AGE receptors CD36 and RAGE,8, 9 and DR PPE binding to bone marrow-derived dendritic cells (BMDCs) was partially inhibited by scavenger receptor blockers (Fig 2, A and B). Consistent with this, DR PPE was more efficient than raw PPE in inhibiting the in vitro presentation of maleylated or AGE-modified hen egg lysozyme (HEL) by BMDCs to a HEL-specific T cell hybridoma (Fig 2, C, and see Online Repository Methods).

FIG 2. AGE adducts in dry-roasted (DR) peanuts.

FIG 2

A, Raw and DR Ara h1 recombinant receptor binding by ELISA. B, BMDC binding of fluoresceinated Ara h1 and its inhibition, by flow cytometry. C, DR or raw PPE competition for maleylated or AGE-HEL BMDC presentation to 3A9 hybridoma. D and E, PPE-pulsed BMDC surface marker and cytokine analysis by flow cytometry and Luminex®. F, PPE co-culture with HEL in BMDC presentation to 3A9 hybridoma. H, NFkB/AP1 activation in RAW-Blue cells pulsed with HEL, PPE or LPS ± polymixin B.

These results confirm the presence of biologically active AGE adducts in DR peanut proteins, and their ability to target these proteins to antigen presenting cells. Phenotypic and cytokine profile analyses of peanut-pulsed BMDCs, however, revealed no classical activation by raw or DR peanut preparations as compared to lipopolysaccharide (LPS) (Fig 2, D and E, and see Fig E7, AC, in this article’s Online Repository at www.jacionline.org). Moreover, by contrast with direct AGE-relevant modification of HEL that showed increased presentation to an HEL-specific T cell hybridoma, DR PPE-pulsed DCs failed to enhance presentation of unmodified HEL, reinforcing the absence of DR PPE-elicited DC costimulation (Fig 2, F, and see Fig E8 in this article’s Online Repository at www.jacionline.org). Finally, we confirmed the lack of canonical pro-inflammatory activation by raw or DR PPE and CPH preparations using sensitive NFκB/AP1 murine and human monocyte/macrophage reporter lines RAW-Blue and THP1 Blue (Fig 2, G, and see Fig E9, AC in this article’s Online Repository at www.jacionline.org). These data suggest that, in accord with other reports,5, 10 enhanced targeting and presentation via AGE receptors rather than conventional DC maturation may be implicated in the increased immunogenicity of DR peanut antigens in vivo. The complex variety of AGE adducts and the diversity and redundancy of their receptors means that more study is required to elucidate the precise receptors and pathways implicated in DC uptake and presentation of peanut antigens to T cells.

This report provides the first in vivo support for the enhanced immunogenicity of DR peanuts, probably mediated by oxidation-driven generation of AGE-related adducts in peanut allergens. Two other major findings with clinical implications are: i) high reactivity of DR peanut-derived responses to raw peanut antigens suggesting that roasting may have a more important impact on the immunogenicity rather than antigenicity of peanuts at the priming step of sensitization, which could be further aggravated by subsequent exposure to raw antigens ii) cutaneous sensitization provoking further hypersensitivity in the gut upon oral antigen exposure. A better understanding of how high-temperature antigen modification, such as peanut dry roasting, leads to allergic sensitization should inform future preventive strategies including those concerning early age exposure, and therapeutic measures such as the choice and route of antigen delivery in desensitization strategies.

Supplementary Material

Acknowledgments

We thank The Sir William Dunn School of Pathology PSB staff and Nigel Rust for technical support. QJS is a James Martin Senior Fellow and a Jenner Vaccine Institute Investigator.

Declaration of all sources of funding: This work was supported by the National Institute for Health Research Oxford Biomedical Research Centre UK, and funding from NIH (AI095466, AI09560, and AI097333), and Swiss National Science Foundation Prospective and Advanced Research Fellowships (PBBEP3_130438 and PA00P3_136468 to M.N.).

ABBREVATIONS

AGE

Advanced glycation end products

APC

Antigen presenting cell

BMDC

Bone marrow-derived dendritic cells

CPH

Crude peanut homogenate

FA

Food allergy

GI

Gastrointestinal

IC

Epicutaneous

LP

Lamina propria

LPS

Lipopolysaccharide

MLN

Mesenteric lymph node

PPE

Peanut protein extract

SC

Subcutaneous

Th2

T helper type 2

References

  • 1.Beyer K, Morrow E, Li XM, Bardina L, Bannon GA, Burks AW, et al. Effects of cooking methods on peanut allergenicity. J Allergy Clin Immunol. 2001;107:1077–81. doi: 10.1067/mai.2001.115480. [DOI] [PubMed] [Google Scholar]
  • 2.Lee AJ, Thalayasingam M, Lee BW. Food allergy in Asia: how does it compare? Asia Pac Allergy. 2013;3:3–14. doi: 10.5415/apallergy.2013.3.1.3. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 3.Prusak A, Schlegel-Zawadzka M, Boulay A, Rowe G. Characteristics of the peanut chain in Europe - implications for peanut allergy. Acta Sci Pol Technol Aliment. 2014;13:321–33. doi: 10.17306/j.afs.2014.3.10. [DOI] [PubMed] [Google Scholar]
  • 4.Maleki SJ, Chung SY, Champagne ET, Raufman JP. The effects of roasting on the allergenic properties of peanut proteins. J Allergy Clin Immunol. 2000;106:763–8. doi: 10.1067/mai.2000.109620. [DOI] [PubMed] [Google Scholar]
  • 5.Ilchmann A, Burgdorf S, Scheurer S, Waibler Z, Nagai R, Wellner A, et al. Glycation of a food allergen by the Maillard reaction enhances its T-cell immunogenicity: role of macrophage scavenger receptor class A type I and II. J Allergy Clin Immunol. 2010;125:175–83. e1–11. doi: 10.1016/j.jaci.2009.08.013. [DOI] [PubMed] [Google Scholar]
  • 6.Hebling CM, McFarland MA, Callahan JH, Ross MM. Global proteomic screening of protein allergens and advanced glycation endproducts in thermally processed peanuts. J Agric Food Chem. 2013;61:5638–48. doi: 10.1021/jf303554t. [DOI] [PubMed] [Google Scholar]
  • 7.Lack G. Update on risk factors for food allergy. J Allergy Clin Immunol. 2012;129:1187–97. doi: 10.1016/j.jaci.2012.02.036. [DOI] [PubMed] [Google Scholar]
  • 8.Mueller GA, Maleki SJ, Johnson K, Hurlburt BK, Cheng H, Ruan S, et al. Identification of Maillard reaction products on peanut allergens that influence binding to the receptor for advanced glycation end products. Allergy. 2013;68:1546–54. doi: 10.1111/all.12261. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 9.Ohgami N, Nagai R, Ikemoto M, Arai H, Kuniyasu A, Horiuchi S, et al. Cd36, a member of the class b scavenger receptor family, as a receptor for advanced glycation end products. J Biol Chem. 2001;276:3195–202. doi: 10.1074/jbc.M006545200. [DOI] [PubMed] [Google Scholar]
  • 10.Moghaddam AE, Gartlan KH, Kong L, Sattentau QJ. Reactive carbonyls are a major th2-inducing damage-associated molecular pattern generated by oxidative stress. J Immunol. 2011;187:1626–33. doi: 10.4049/jimmunol.1003906. [DOI] [PubMed] [Google Scholar]

Associated Data

This section collects any data citations, data availability statements, or supplementary materials included in this article.

Supplementary Materials

RESOURCES